Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors

Petri I. Mäkinen(University of Eastern Finland), Seppo Ylä‐Herttuala(University of Eastern Finland), Janne Heikkilä(Kuopio University Hospital), Mikko P. Turunen(University of Eastern Finland), Jussi Aarnio(Kuopio University Hospital), Jari P. Lappalainen(University of Eastern Finland), Markku Lähteenvuo(University of Eastern Finland), Suvi E. Heinonen(University of Eastern Finland), Pia Leppänen(University of Eastern Finland)
Cardiovascular Research
July 15, 2010
10.1093/cvr/cvq235
Cited by 119

Related Papers

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
|Journal of Clinical Investigation|1989|1.9k
Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics
|Circulation Research|2020|577
Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent Mechanisms
|Circulation|2009|195
Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema
|Circulation|2011|181
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder
|JAMA Psychiatry|2018|147